Rosenman Herm
Natera, Inc. · Director
Rosenman Herm serves as a Director at Natera, Inc., a company specializing in genetic testing and diagnostics. His recent trading activity, documented through SEC Form 4 filings, highlights a pattern of sale transactions within the healthcare sector. From December 16, 2025, to June 30, 2026, Herm disclosed a total of 11 transactions, all related to Natera, Inc. (NTRA), with sale amounts ranging from $4.1 million to $3.3 million. Notably, his largest disclosed sale occurred on December 16, 2025, valued at approximately $4.98 million.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $4M16.5k shares | SellJun 24, 2026 | $250.00 | $265.25 |